Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

EIKNEikon Therapeutics, Inc.

Nasdaq · CIK 0001861123
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts112

Identity from submissions API

NameEikon Therapeutics, Inc.
CIK0001861123
TickersEIKN
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN842807586
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone341-777-0566
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
230 HARRIET TUBMAN WAY
MILLBRAE
CA
94030
CA
Mailing address
230 HARRIET TUBMAN WAY
MILLBRAE
CA
94030
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

69 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-12 10-Q 10-Q 0001193125-26-456835 001-43085 261542956 34 10473931 1 1
2026-11-12 8-K 8-K 2.02,9.01 0001193125-26-456794 001-43085 261542905 34 295679 1 1
2026-10-26 8-K 8-K 7.01,8.01,9.01 0001193125-26-430860 001-43085 261483365 34 210312 1 1
2026-10-23 8-K 8-K 7.01,8.01,9.01 0001193125-26-429549 001-43085 261480110 34 258062 1 1
2026-10-07 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002331 005-95483 261446097 34 11566
2026-10-02 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-113112 005-95483 261434140 34 10108
2026-09-08 4 4 0001193125-26-385268 22303
2026-08-14 8-K 8-K 7.01,9.01 0001193125-26-349936 001-43085 261275655 34 15826193 1 1
2026-08-13 10-Q 10-Q 0001193125-26-349185 001-43085 261273415 34 10018475 1 1
2026-08-13 8-K 8-K 2.02,9.01 0001193125-26-349154 001-43085 261273236 34 310216 1 1
2026-08-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-001987 005-95483 261246967 34 11557
2026-08-03 8-K 8-K 5.02 0001193125-26-330710 001-43085 261233704 34 144744 1 1
2026-06-15 3 3 0001193125-26-271167 19964
2026-06-10 8-K 8-K 5.02 0001193125-26-265861 001-43085 261079846 34 153122 1 1
2026-06-01 8-K 8-K 7.01,8.01,9.01 0001193125-26-249725 001-43085 261047171 34 22097062 1 1
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001720215-26-000006 005-95483 26987944 34 20181
2026-05-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-221988 005-95483 26974698 34 6953
2026-05-11 10-Q 10-Q 0001193125-26-216791 001-43085 26963357 34 11333839 1 1
2026-05-11 8-K 8-K 2.02,7.01,9.01 0001193125-26-216744 001-43085 26963136 34 16102480 1 1
2026-05-06 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-001183 005-95483 26946680 34 11067
2026-04-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002052113-26-000458 005-95483 26916022 34 10791
2026-03-30 8-K 8-K 2.02,9.01 0001193125-26-130449 001-43085 26810034 34 186832 1 1
2026-03-30 10-K 10-K 0001193125-26-130395 001-43085 26809950 34 53083727
2026-03-04 4 4 0001193125-26-091798 5257
2026-03-04 4 4 0001193125-26-091787 5222
2026-03-04 4 4 0001193125-26-091783 5220
2026-03-04 4 4 0001193125-26-091779 5342
2026-03-04 4 4 0001193125-26-091771 5301
2026-03-04 4 4 0001193125-26-091770 5274
2026-03-04 4 4 0001193125-26-091767 5261
2026-02-18 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001999371-26-003632 005-95483 26648522 34 15521
2026-02-12 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-26-049209 005-95483 26628156 34 140418
2026-02-11 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-013367 005-95483 26620783 34 28620
2026-02-10 4 4 0001193125-26-044903 9756
2026-02-09 4 4 0001193125-26-043320 49089
2026-02-06 4 OWNERSHIP DOCUMENT 0001104659-26-011662 80155
2026-02-06 4 4 0001193125-26-041555 4319
2026-02-06 4 4 0001193125-26-041549 36127
2026-02-06 4 4 0001193125-26-041544 44920
2026-02-06 S-8 S-8 0001193125-26-041241 333-293272 26607983 33 246237 1 1
2026-02-06 8-K 8-K 5.03,9.01 0001193125-26-041201 001-43085 26607793 34 197149 1 1
2026-02-05 424B4 424B4 0001193125-26-039375 333-292633 26602881 33 14083739
2026-02-04 3 3 0001193125-26-038199 25318
2026-02-04 3 3 0001193125-26-038168 39067
2026-02-04 3 3 0001193125-26-038167 21783
2026-02-04 3 3 0001193125-26-038164 20503
2026-02-04 3 3 0001193125-26-038158 34949
2026-02-04 3 3 0001193125-26-038147 17529
2026-02-04 3 3 0001193125-26-038145 16092
2026-02-04 3 3 0001193125-26-038139 23208
2026-02-04 3 3 0001193125-26-038137 21978
2026-02-04 3 3 0001193125-26-038136 20661
2026-02-04 3 3 0001193125-26-038127 18970
2026-02-04 3 3 0001193125-26-038125 7337
2026-02-04 3 3 0001193125-26-038115 27381
2026-02-04 S-1MEF S-1MEF 0001193125-26-037993 333-293213 26599858 33 188513 1 1
2026-02-04 CERT EIKN_8A_Cert_1861123.pdf 0001354457-26-000137 001-43085 26597700 34 596428
2026-01-30 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000406 333-292633 26585550 33 1734
2026-01-28 8-A12B 8-A12B 0001193125-26-026711 001-43085 26570363 34 14622
2026-01-28 S-1/A S-1/A 0001193125-26-025565 333-292633 26568111 33 15406859 1 1
2026-01-09 S-1 S-1 0001193125-26-008888 333-292633 26523031 33 19299068 1 1
2025-12-12 DRS/A filename1.htm 0001193125-25-317659 377-07990 251568646 33 14716012
2025-09-26 DRS/A filename1.htm 0001193125-25-220186 377-07990 251349547 33 12581208
2025-07-01 DRS/A filename1.htm 0000950123-25-006156 377-07990 251094003 33 12979564
2025-05-09 DRS filename1.htm 0000950123-25-004458 377-07990 25929840 33 14199162
2025-02-28 D xslFormDX01/primary_doc.xml 06b 0001861123-25-000001 021-539574 25689871 33 11239
2023-06-01 D xslFormDX01/primary_doc.xml 06b 0001861123-23-000001 021-483121 23984309 33 15732
2022-01-06 D xslFormDX01/primary_doc.xml 06b 0001861123-22-000001 021-428246 22515643 33 10376
2021-05-13 D xslFormDX01/primary_doc.xml 06b 0001861123-21-000001 021-399311 21918869 33 8912

Latest XBRL company facts

One latest value per concept from companyfacts (112 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 54.19M 2026-11-02 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 51.24M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 6.12M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 1.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 58.24M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 1.56B 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 6.30M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 10.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 8.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap Assets Assets USD 706.20M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap AssetsCurrent Assets, Current USD 478.13M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 197,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 98.48M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 106.77M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -6.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 43.59 2025-02-28 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 11.03M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 54.18M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 54.18M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap CommonStockValue Common Stock, Value, Issued USD 5,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 2.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap Depreciation Depreciation USD 15.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -5.43 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -5.43 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 20.87M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 53.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 5.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -7.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 5.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 13.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 11,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap LeaseDepositLiability Lease Deposit Liability USD 6.70M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 530.61M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 39.31M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 35.91M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 36.78M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 38.29M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 10.02M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 281.06M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap Liabilities Liabilities USD 321.91M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 706.20M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap LiabilitiesCurrent Liabilities, Current USD 66.27M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap LossContingencyAccrualCarryingValueCurrent Loss Contingency, Accrual, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 363.24M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 83.83M 2026-03-31 2026 Q1 10-Q 2026-05-11 0001193125-26-216791
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 349.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -131.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -223.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -257.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -257.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap OperatingExpenses Operating Expenses USD 271.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -271.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap OperatingLeaseCost Operating Lease, Cost USD 23.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 10.28M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 249.55M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 8.91M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 240.63M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 91.17M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.128 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 236,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 463,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 15.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD -99,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap PaymentsForProceedsFromTenantAllowance Payments for (Proceeds from) Tenant Allowance USD 49.70M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001193125-26-349185
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 436.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 932,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 50.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 16.01M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 349.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 459,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock Proceeds from Issuance of Redeemable Convertible Preferred Stock USD 350.15M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 305.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -257.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 186.80M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 128.56M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap RedeemableNoncontrollingInterestEquityPreferredCarryingAmount Redeemable Noncontrolling Interest, Equity, Preferred, Carrying Amount USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 217.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap RestrictedCash Restricted Cash USD 8.28M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 400,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 7.88M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap RestructuringCharges Restructuring Charges USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.18B 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 9.83M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap SegmentReportingOtherItemAmount SegmentReportingOtherItemAmount USD 13.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 10.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost Share-based Payment Arrangement, Plan Modification, Incremental Cost USD 2.40M 2025-04-02 2025-05-05 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 384.29M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 1.16B 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 3.75M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 158,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 1.16B 2025-12-31 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap VariableLeaseCost Variable Lease, Cost USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 47.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation shares 382 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 47.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456835

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →